Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin-Tetracycline vs Metronidazole-Tetracycline for H. pylori in Penicillin-Allergic Patients
NCT05129176Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Nov 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in Helicobacter pylori infection, sponsored by Shandong University. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05129176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05129176.